@prefix eprel: <http://eprints.org/relation/> .
  @prefix geo: <http://www.w3.org/2003/01/geo/wgs84_pos#> .
  @prefix event: <http://purl.org/NET/c4dm/event.owl#> .
  @prefix doi: <https://doi.org/> .
  @prefix epid: <https://arxiv.universalpublishings.com/id/> .
  @prefix dc: <http://purl.org/dc/elements/1.1/> .
  @prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
  @prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
  @prefix cc: <http://creativecommons.org/ns#> .
  @prefix bibo: <http://purl.org/ontology/bibo/> .
  @prefix owl: <http://www.w3.org/2002/07/owl#> .
  @prefix foaf: <http://xmlns.com/foaf/0.1/> .
  @prefix skos: <http://www.w3.org/2004/02/skos/core#> .
  @prefix void: <http://rdfs.org/ns/void#> .
  @prefix ep: <http://eprints.org/ontology/> .
  @prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
  @prefix dct: <http://purl.org/dc/terms/> .

<>
	foaf:primaryTopic <https://arxiv.universalpublishings.com/id/eprint/52081>;
	rdfs:comment "The repository administrator has not yet configured an RDF license."^^xsd:string .

<https://arxiv.universalpublishings.com/id/eprint/52081#authors>
	rdf:_1 <https://arxiv.universalpublishings.com/id/person/ext-de39085ef5e55ce6d79cacf3f39dbb31> .

<https://arxiv.universalpublishings.com/id/eprint/52081/>
	dc:format "text/html";
	dc:title "HTML Summary of #52081 \n\nTHE IMPACT OF METABOLIC SYNDROME ON THE PROGNOSIS AND COURSE OF ENDOMETRIAL CANCER: CLINICAL, BIOCHEMICAL ASPECTS AND THERAPEUTIC APPROACHES\n\n";
	foaf:primaryTopic <https://arxiv.universalpublishings.com/id/eprint/52081> .

<https://arxiv.universalpublishings.com/id/eprint/52081>
	bibo:abstract "Endometrial cancer is one of the most common gynecological malignancies worldwide, with its incidence closely associated with metabolic disorders. Metabolic syndrome, characterized by obesity, insulin resistance, dyslipidemia, and hypertension, has been identified as a significant risk factor influencing the development, progression, and prognosis of endometrial cancer. This article examines the impact of metabolic syndrome on the clinical course and outcomes of endometrial cancer, focusing on underlying biochemical mechanisms and current therapeutic approaches. Evidence suggests that metabolic syndrome contributes to tumor progression through hormonal imbalance, chronic inflammation, and altered metabolic signaling pathways. Understanding these interactions is essential for improving prognosis and developing individualized treatment strategies for patients with endometrial cancer."^^xsd:string;
	bibo:authorList <https://arxiv.universalpublishings.com/id/eprint/52081#authors>;
	bibo:status <http://purl.org/ontology/bibo/status/published>;
	dct:creator <https://arxiv.universalpublishings.com/id/person/ext-de39085ef5e55ce6d79cacf3f39dbb31>;
	dct:date "2026-02-07";
	dct:isPartOf <https://arxiv.universalpublishings.com/id/repository>,
		<https://arxiv.universalpublishings.com/id/publication/ext-dbed9f2336796bf48bec732d36c8b42e>;
	dct:publisher <https://arxiv.universalpublishings.com/id/org/ext-dbed9f2336796bf48bec732d36c8b42e>;
	dct:title "THE IMPACT OF METABOLIC SYNDROME ON THE PROGNOSIS AND COURSE OF ENDOMETRIAL CANCER: CLINICAL, BIOCHEMICAL ASPECTS AND THERAPEUTIC APPROACHES"^^xsd:string;
	rdf:type bibo:AcademicArticle,
		bibo:Article,
		ep:ArticleEPrint,
		ep:EPrint;
	rdfs:seeAlso <https://arxiv.universalpublishings.com/id/eprint/52081/> .

<https://arxiv.universalpublishings.com/id/org/ext-dbed9f2336796bf48bec732d36c8b42e>
	foaf:name "South Aral Region Medical Journal"^^xsd:string;
	rdf:type foaf:Organization .

<https://arxiv.universalpublishings.com/id/person/ext-de39085ef5e55ce6d79cacf3f39dbb31>
	foaf:familyName "Akbarova"^^xsd:string;
	foaf:givenName "Maftuna"^^xsd:string;
	foaf:name "Maftuna Akbarova"^^xsd:string;
	rdf:type foaf:Person .

<https://arxiv.universalpublishings.com/id/publication/ext-dbed9f2336796bf48bec732d36c8b42e>
	foaf:name "South Aral Region Medical Journal"^^xsd:string;
	rdf:type bibo:Collection .